Sort   by:  
 Page size 
UnknownSotrovimab to prevent severe COVID-19 in high-risk patients infected with Omicron BA.2.
Not available
S-EPMC9254651 | biostudies-literature
UnknownTime to negative PCR conversion amongst high-risk patients with mild-to-moderate Omicron BA.1 and BA.2 COVID-19 treated with sotrovimab or nirmatrelvir.
Not available
S-EPMC9794519 | biostudies-literature
UnknownsST2 is a key outcome biomarker in COVID-19: insights from discovery randomized trial.
Not available
S-EPMC12022249 | biostudies-literature
UnknownRepurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results.
Not available
S-EPMC7727327 | biostudies-literature
Sort   by:  
 Page size